European Union

Nachrichten

Ireland: EUR 30 million EIB backing for Nuritas

Ireland: EUR 30 million EIB backing for Nuritas

The EIB today agreed a EUR 30 million facility to support investment by Dublin based biotech company, Nuritas, to further increase and accelerate development of artificial intelligence and DNA analysis to improve global healthcare. Representing the first direct EIB financing for an Irish biotech company, the new support will allow the company to access tranched financing as required to scale up the development of the rapidly growing company. 

Date: 
Donnerstag, 29 November, 2018 - 00:00
Back to top